Multiple endocrine neoplasia type 2 diagnostic criteria: Difference between revisions
(Created page with "__NOTOC__ {{}} {{CMG}}; {{AE} {{Ammu}} ==Overview== ==Diagnostic Criteria== The current clinical criteria for detecting Multiple endocrine neoplasia type 2 is as follows:<ref...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE} {{Ammu}} | {{CMG}}; {{AE} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Line 15: | Line 15: | ||
|} | |} | ||
<br><br><br><br><br><br> | <br><br><br><br><br><br> | ||
==Reference== | |||
{{Reflist|2}} |
Revision as of 02:49, 5 October 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 diagnostic criteria On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 diagnostic criteria |
FDA on Multiple endocrine neoplasia type 2 diagnostic criteria |
CDC on Multiple endocrine neoplasia type 2 diagnostic criteria |
Multiple endocrine neoplasia type 2 diagnostic criteria in the news |
Blogs on Multiple endocrine neoplasia type 2 diagnostic criteria |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; {{AE} Ammu Susheela, M.D. [2]
Overview
Diagnostic Criteria
The current clinical criteria for detecting Multiple endocrine neoplasia type 2 is as follows:[1]
Clinical criteria for diagnosis of Multiple endocrine neoplasia type 2 |
---|
2 or more specific endocrine tumors (medullary thyroid carcinoma, pheochromocytoma or parathyroid hyperplasia) |
Familial medullary thyroid carcinoma is diagnosed in families with four or more cases of medullary thryoid cacrinoma without pheochromocytoma and parathyroid adenoma |
Multiple endocrine neoplasia type 2b is diagnosed if there is early onset of medullary throid carcinoma, mucosal neuromas of lips and tongue, disctinctive facial features with enlarged lips and marfanoid body habitus |